The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-((4-chlorobenzyl)amino)-3-((4-hydroxy-1-(3-phenylpropanoyl)piperidin-4-yl)methyl)quinazolin-4(3H)-one ID: ALA4871556
PubChem CID: 164622011
Max Phase: Preclinical
Molecular Formula: C30H33ClN4O3
Molecular Weight: 533.07
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCc1ccccc1)N1CCC(O)(CN2C=Nc3cc(NCc4ccc(Cl)cc4)ccc3C2O)CC1
Standard InChI: InChI=1S/C30H33ClN4O3/c31-24-9-6-23(7-10-24)19-32-25-11-12-26-27(18-25)33-21-35(29(26)37)20-30(38)14-16-34(17-15-30)28(36)13-8-22-4-2-1-3-5-22/h1-7,9-12,18,21,29,32,37-38H,8,13-17,19-20H2
Standard InChI Key: QYSZIFSBJLVEHG-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
-0.5497 -26.8110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1580 -26.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8673 -26.8056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5735 -26.3944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2811 -26.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2699 -25.1693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5672 -25.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9842 -25.5751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9837 -26.3892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6847 -26.7943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3905 -26.3899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3910 -25.5758 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6855 -25.1661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6848 -24.3489 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0993 -25.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8064 -25.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7993 -26.3944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5024 -26.8040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2131 -26.4000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2163 -25.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5088 -25.1677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0134 -24.7840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9186 -26.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9143 -27.6295 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6285 -26.4075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3340 -26.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0439 -26.4150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7471 -26.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4565 -26.4278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4613 -25.6097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7508 -25.1975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0443 -25.6040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2615 -26.4017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9673 -26.8122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9617 -27.6303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2479 -28.0361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5474 -27.6231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6676 -28.0425 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 9 1 0
8 6 1 0
6 7 2 0
7 4 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 1 0
12 15 1 0
15 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
16 22 1 0
19 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
1 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 1 1 0
35 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 533.07Molecular Weight (Monoisotopic): 532.2241AlogP: 4.90#Rotatable Bonds: 8Polar Surface Area: 88.40Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.62CX Basic pKa: 7.41CX LogP: 3.53CX LogD: 3.24Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.38Np Likeness Score: -0.61
References 1. Li P, Liu Y, Yang H, Liu HM.. (2021) Design, synthesis, biological evaluation and structure-activity relationship study of quinazolin-4(3H)-one derivatives as novel USP7 inhibitors., 216 [PMID:33684824 ] [10.1016/j.ejmech.2021.113291 ]